Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Multiple Myeloma
Study Phase
Phase 3
Study Completion Date
October 2012
NCT01989572Uploaded 10-31-2018
Access via NCI by Request
PDS UID: nci-data-365
A Randomized, Placebo-Controlled Phase III Trial of Yeast Derived GM-CSF Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With "No Evidence of Disease" After Complete Surgical Resection of "Locally Advanced" and/or Stage IV Melanoma
Files: NCT01989572-D2
Data DictionaryNCT01989572-D2-Data-Dictionary.pdf
DATANCT01989572-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT01989572-D1
Data DictionaryNCT01989572-D1-Data-Dictionary.pdf
DATANCT01989572-D1-Dataset.csv
OTHERREADME.pdf